Interview reveals insights on anti-angiogenic drug testing using a hypoxic zebrafish model, highlighting advances in biotechnology.
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping researchers promote themselves alongside their papers. Vinoth S is first author on ‘ A pro-angiogenic and hypoxic zebrafish model as a novel platform for anti-angiogenic drug testing’, published in BiO. Vinoth conducted the research described in this article while a PhD research scholar in Dr S. Kirankumar's lab at SRM Institute of Science and Technology, Kattankulathur, Chennai, India. He is now a project scientist-I in the lab of Dr Rajeeb K. Swain at the Institute of Life Sciences, Bhubaneswar, India, investigating biotechnology and specialising in disease modelling using zebrafish and gene-editing technologies to support therapeutic development and drug testing.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: